Skip to content
Search

Latest Stories

1 in 3 ethnic minorities need 3 or more GP visits for cancer diagnosis, new survey reveals

1 in 3 ethnic minorities need 3 or more GP visits for cancer diagnosis, new survey reveals
Currently, only 60 per cent of cancer diagnoses are taking place before the cancer has progressed

The latest findings from the National Cancer Patient Experience Survey 2022 by QualityWatch, a joint programme with the Nuffield Trust and the Health Foundation shed light on concerning disparities faced by ethnic minority communities in the UK healthcare system.

Despite strides in cancer care, the survey highlights persistent challenges in easy and equitable access to timely diagnosis and quality communication, particularly for individuals from Mixed, Black, or Asian backgrounds.


Key insights from the survey underscored that individuals from ethnic minority groups often require a higher number of interactions with healthcare professionals before receiving a cancer diagnosis.

Notably, one in three people from Mixed, Black, or Asian ethnicities needed three or more visits to a GP practice, compared to the average of one in five across the population.

These delays in diagnosis can have significant implications for treatment outcomes and overall patient experience.

Moreover, the survey revealed concerning trends regarding the quality of communication following a cancer diagnosis among ethnic minority patients.

A substantial proportion of patients from deprived areas reported feeling inadequately informed about the reasons for their referrals and faced challenges in fully understanding their diagnosis.

Moreover, the analysis suggested that people from the most deprived populations in England were 21 per cent less likely to be referred for urgent suspected cancer than those from areas with low levels of deprivation.

This highlights systemic barriers in effective patient-provider communication, which are critical for informed decision-making and navigating the complexities of cancer care.

Dr. Liz Fisher, Senior Fellow at the Nuffield Trust, emphasized the urgency of addressing these disparities, noting that early diagnosis is pivotal for improving cancer survival rates.

"Detecting cancer early is vital to improving survival rates, for example, the rate of survival for bowel cancer drops significantly from 80 per cent if caught in stage 2 to 11 per cent at stage four."

She emphasised the need to enhance primary care capacity and provide tailored support for ethnic minority communities as essential to ensure equitable access to timely diagnosis and support services.

Tim Gardner, Assistant Director of Policy at the Health Foundation, echoed these sentiments, stressing the need for sustained investment in primary care to address underlying structural inequities in cancer care delivery.

He further suggested that by prioritizing culturally sensitive approaches and addressing communication barriers, healthcare providers can work towards narrowing the gap in cancer outcomes among most deprived populations.

The Nuffield Trust report also predicted higher chances of NHS missing its own target to have 75 per cent of cancers diagnosed at an early stage by 2028 as efforts to diagnose cancer at earlier stages has flatlined in recent years and currently, only 60 per cent of cancer diagnoses are taking place before the cancer has progressed.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less